Committed to innovation, Da Volterra develops microbiota protecting therapies as well as tools intended to harness potential to help prevent and cure human diseases.
Protecting the intestinal microbiota during antibiotic treatments
Preventing Antibiotic Resistance with Carbapenems
Microbiome Discovery Platform
Discovering metagenomic and metabolomic targets in the intestinal microbiota to support the development of novel therapeutic strategies
Over the years since inception, we have gathered a unique in-house expertise on the intestinal microbiota and its links to the different body functions, antibacterial drugs and other drugs disrupting the microbiota as well as drug delivery technologies.